The Current Ratio as of December 2024 (TTM) for 180 Life Sciences Corp. (ATNF) is 0.19

According to 180 Life Sciences Corp.’s latest financial reports and current stock price. The company's current Current Ratio is 0.19. This represents a change of -60.63% compared to the average of 0.49 of the last 4 quarters.

180 Life Sciences Corp. (ATNF) Historical Current Ratio (quarterly & annually)

How has ATNF Current Ratio performed in the past?

The mean historical Current Ratio of 180 Life Sciences Corp. over the last ten years is 0.79. The current 0.19 Current Ratio has changed 2.34% with respect to the historical average. Over the past ten years (40 quarters), ATNF's Current Ratio was at its highest in in the June 2017 quarter at 5.39. The Current Ratio was at its lowest in in the March 2020 quarter at 0.03.

180 Life Sciences Corp. (ATNF) Current Ratio by Quarter and Year

Discovering the peaks and valleys of 180 Life Sciences Corp. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

180 Life Sciences Corp. (ATNF) Average Current Ratio

How has ATNF Current Ratio performed in the past?

The current Current Ratio of 180 Life Sciences Corp. (ATNF) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

180 Life Sciences Corp. (ATNF) Current Ratio vs. Peers

How is ATNF’s Current Ratio compared to its peers?

180 Life Sciences Corp.’s Current Ratio is less than Zura Bio Limited (10.36), less than Phio Pharmaceuticals Corp. (6.38), less than Sonnet BioTherapeutics Holdings, Inc. (0.66), less than Cardio Diagnostics Holdings, Inc. (8.51), less than Altamira Therapeutics Ltd. (1.38), less than Immix Biopharma, Inc. (3.47), less than Enveric Biosciences, Inc. (5.17), less than Palisade Bio, Inc. (3.31), less than CNS Pharmaceuticals, Inc. (1.82), less than eFFECTOR Therapeutics, Inc. (1.03), less than Navidea Biopharmaceuticals, Inc. (0.56), less than ZyVersa Therapeutics, Inc. (33.83), less than Apexigen, Inc. (1.29),

Build a custom stock screener for 180 Life Sciences Corp. (ATNF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like 180 Life Sciences Corp. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

180 Life Sciences Corp. (ATNF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like 180 Life Sciences Corp. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.